MediciNova, Inc. (MNOV)
1.76
+0.01
(+0.57%)
USD |
NASDAQ |
Sep 09, 14:40
MediciNova Debt to Equity Ratio : 0.0031 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0031 |
| March 31, 2026 | 0.0042 |
| December 31, 2025 | 0.0051 |
| September 30, 2025 | 0.0058 |
| June 30, 2025 | 0.0064 |
| March 31, 2025 | 0.0071 |
| December 31, 2024 | 0.0077 |
| September 30, 2024 | 0.0083 |
| June 30, 2024 | 0.0086 |
| March 31, 2024 | 0.0095 |
| December 31, 2023 | 0.01 |
| September 30, 2023 | 0.0103 |
| June 30, 2023 | 0.0111 |
| March 31, 2023 | 0.0093 |
| December 31, 2022 | 0.0097 |
| September 30, 2022 | 0.0023 |
| June 30, 2022 | 0.0024 |
| March 31, 2022 | 0.002 |
| December 31, 2021 | 0.0099 |
| September 30, 2021 | 0.0017 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.0026 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.0053 |
| September 30, 2019 | 0.0061 |
| June 30, 2019 | 0.0064 |
| March 31, 2019 | 0.0046 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.0002 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 40.43M |
| Total Liabilities (Quarterly) | 3.163M |
| Shareholders Equity (Quarterly) | 37.27M |
| Current Ratio | 8.754 |
| Net Debt Paydown Yield | 0.07% |